Merck & Co., Inc. (0QAH)
LSE
141.12
+1.21 (+0.86%)
Closed
Oct 6, 2026
Day's Range
139.30142.10
52 wk Range
81.90157.32
Financial Statements - 0QAH - Merck & Co., Inc.
Revenue
65.01B▲ 1.3%
Net Income
18.26B▲ 6.6%Net Margin 28.1%
EBITDA
29.10B▲ 11.0%
Free Cash Flow
12.36B▼ 31.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 65.01B | 64.16B | 60.11B | 59.28B | 48.70B | 41.51B |
| Cost of Goods | 16.38B | 15.19B | 16.12B | 17.41B | 13.62B | 13.61B |
| Gross Profit | 48.62B | 48.97B | 43.98B | 41.87B | 35.07B | 27.90B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 22.10B | 20.22B | 2.95B | 18.28B | 13.19B | 5.54B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -26M | 571M | -284M | -1.03B | 1.45B | 1.08B |
| Pre Tax Income | 21.06B | 19.93B | 1.88B | 16.44B | 13.87B | 5.86B |
| Income Tax | 2.80B | 2.80B | 1.51B | 1.91B | 1.52B | 1.34B |
| Net Income | 18.26B | 17.13B | 377M | 14.52B | 12.35B | 4.52B |
| EPS Basic | 7.376466 | 6.771937 | 0.14 | 5.73 | 5.16 | 2.793031 |
| EPS Diluted | 7.28 | 6.74 | 0.14 | 5.71 | 5.14 | 2.78 |
| Basic Shares Outstanding | 2.47B | 2.52B | 2.60B | 2.53B | 2.53B | 2.53B |
| Diluted Shares Outstanding | 2.47B | 2.52B | 2.60B | 2.53B | 2.53B | 2.53B |
| Ebit | 22.42B | 21.20B | 3.03B | 17.40B | 14.68B | 6.69B |
| Ebitda | 29.10B | 26.22B | 7.53B | 23.30B | 16.91B | 9.56B |
| Net Income Continuous Operations | 18.26B | 17.13B | 377M | 14.52B | 12.35B | 4.52B |
| Minority Interests | -9M | -16M | -12M | -7M | 691M | 2.54B |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
